Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-07

Clinical Trial Update: Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing polyethylene glycol 3350 with tegaserod in chronic constipation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyethylene glycol 3350 (polyethylene glycol 3350)
  • Zelnorm (tegaserod)

Snippet

Sponsor: Braintree Laboratories | Conditions: Constipation | Phase 4 | Status: COMPLETED